Conexeu Sciences is trading 10.25% down at $3.54, with no October 16 company announcement or confirmed catalyst identified. - Latest company news was an October 15 private placement of approximately $5 million, priced at $3.00 per unit; each unit included a share and a warrant. Available reporting does not link it directly to the decline. - Biotech-sector weakness may be contributing: XBI was down 2.06%, alongside mixed major indexes, but this does not establish the cause of the larger individual move. No trading-volume information was provided.